The Motley Fool
04 Sept 2026, 03:56 UTC · 9w ago
Why MiniMed Stock Was Soaring This Week
Impact · against what's priced in
MiniMed Group's strong Q1 results and shift to breakeven provide a positive catalyst, though the modest guidance bump is less significant than the bottom-line milestone. The successful U.S. launch of the Flex pump and Simplera monitor establishes a new growth trajectory for the ecosystem.
- MMED+0.70
No priced-in read yet
- In context
The company reached a breakeven bottom line, eliminating the $19 million loss from the prior year, and beat revenue expectations with $843 million in sales. The successful U.S. rollout of the MiniMed Flex and Simplera devices provides a concrete driver for future account growth.
Read from the article alone
